DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Dismiss
Open main menu
Search
For You
AI
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
United States
World
Replimune News
Top stories
Stocks
Pharma
Business
FDA Rejects Replimune’s RP1 Melanoma Drug, Stock Sinks 75%
Authors
15
12 days ago
Latest stories